These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1833 related items for PubMed ID: 27224243

  • 21. Effects of combinations of Xiexin decoction constituents on diabetic nephropathy in rats.
    Wu JS, Liu Y, Shi R, Lu X, Ma YM, Cheng NN.
    J Ethnopharmacol; 2014 Nov 18; 157():126-33. PubMed ID: 25278183
    [Abstract] [Full Text] [Related]

  • 22. Danzhi Jiangtang Capsule ameliorates kidney injury via inhibition of the JAK-STAT signaling pathway and increased antioxidant capacity in STZ-induced diabetic nephropathy rats.
    Sun M, Bu W, Li Y, Zhu J, Zhao J, Zhang P, Gu L, Zhang W, Fang Z.
    Biosci Trends; 2019 Jan 22; 12(6):595-604. PubMed ID: 30606979
    [Abstract] [Full Text] [Related]

  • 23. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
    Bishnoi HK, Mahadevan N, Balakumar P.
    Pharmacol Res; 2012 Oct 22; 66(4):349-56. PubMed ID: 22796657
    [Abstract] [Full Text] [Related]

  • 24. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
    Cha DR, Zhang X, Zhang Y, Wu J, Su D, Han JY, Fang X, Yu B, Breyer MD, Guan Y.
    Diabetes; 2007 Aug 22; 56(8):2036-45. PubMed ID: 17536062
    [Abstract] [Full Text] [Related]

  • 25. [Mechanisms and effects of Abelmoschus manihot preparations in treating chronic kidney disease].
    Chen P, Wan Y, Wang C, Zhao Q, Wei Q, Tu Y, Yin X.
    Zhongguo Zhong Yao Za Zhi; 2012 Aug 22; 37(15):2252-6. PubMed ID: 23189729
    [Abstract] [Full Text] [Related]

  • 26. Huangqi Decoction Ameliorates Streptozotocin-Induced Rat Diabetic Nephropathy through Antioxidant and Regulation of the TGF-β/MAPK/PPAR-γ Signaling.
    Han H, Cao A, Wang L, Guo H, Zang Y, Li Z, Zhang X, Peng W.
    Cell Physiol Biochem; 2017 Aug 22; 42(5):1934-1944. PubMed ID: 28793292
    [Abstract] [Full Text] [Related]

  • 27. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
    Wang ZS, Xiong F, Xie XH, Chen D, Pan JH, Cheng L.
    BMC Nephrol; 2015 Mar 31; 16():44. PubMed ID: 25886386
    [Abstract] [Full Text] [Related]

  • 28. The low dose combination of fenofibrate and rosiglitazone halts the progression of diabetes-induced experimental nephropathy.
    Arora MK, Reddy K, Balakumar P.
    Eur J Pharmacol; 2010 Jun 25; 636(1-3):137-44. PubMed ID: 20347778
    [Abstract] [Full Text] [Related]

  • 29. Potent anti-diabetic effects of MHY908, a newly synthesized PPAR α/γ dual agonist in db/db mice.
    Park MH, Park JY, Lee HJ, Kim DH, Park D, Jeong HO, Park CH, Chun P, Moon HR, Chung HY.
    PLoS One; 2013 Jun 25; 8(11):e78815. PubMed ID: 24244369
    [Abstract] [Full Text] [Related]

  • 30. Renal protection by low dose irbesartan in diabetic nephropathy is paralleled by a reduction of inflammation, not of endoplasmic reticulum stress.
    Hartner A, Cordasic N, Klanke B, Menendez-Castro C, Veelken R, Schmieder RE, Hilgers KF.
    Biochim Biophys Acta; 2014 Apr 25; 1842(4):558-65. PubMed ID: 24418215
    [Abstract] [Full Text] [Related]

  • 31. Nepeta angustifolia C. Y. Wu improves renal injury in HFD/STZ-induced diabetic nephropathy and inhibits oxidative stress-induced apoptosis of mesangial cells.
    Huang S, Tan M, Guo F, Dong L, Liu Z, Yuan R, Dongzhi Z, Lee DS, Wang Y, Li B.
    J Ethnopharmacol; 2020 Jun 12; 255():112771. PubMed ID: 32201300
    [Abstract] [Full Text] [Related]

  • 32. Huangkui capsule attenuates diabetic kidney disease through the induction of mitophagy mediated by STING1/PINK1 signaling in tubular cells.
    Zhu Z, Luan G, Peng S, Fang Y, Fang Q, Shen S, Wu K, Qian S, Jia W, Ye J, Wei L.
    Phytomedicine; 2023 Oct 12; 119():154975. PubMed ID: 37517171
    [Abstract] [Full Text] [Related]

  • 33. A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemia.
    Reifel-Miller A, Otto K, Hawkins E, Barr R, Bensch WR, Bull C, Dana S, Klausing K, Martin JA, Rafaeloff-Phail R, Rafizadeh-Montrose C, Rhodes G, Robey R, Rojo I, Rungta D, Snyder D, Wilbur K, Zhang T, Zink R, Warshawsky A, Brozinick JT.
    Mol Endocrinol; 2005 Jun 12; 19(6):1593-605. PubMed ID: 15831517
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of Huangkui capsule for diabetic nephropathy: A protocol for systematic review and meta-analysis.
    An W, Huang Y, Chen S, Teng T, Liu J, Xu Y.
    Medicine (Baltimore); 2021 Oct 22; 100(42):e27569. PubMed ID: 34678897
    [Abstract] [Full Text] [Related]

  • 35. Understanding the mode-of-action of Cassia auriculata via in silico and in vivo studies towards validating it as a long term therapy for type II diabetes.
    Mohd Fauzi F, John CM, Karunanidhi A, Mussa HY, Ramasamy R, Adam A, Bender A.
    J Ethnopharmacol; 2017 Feb 02; 197():61-72. PubMed ID: 27452659
    [Abstract] [Full Text] [Related]

  • 36. Attenuation of diabetic nephropathy by Sanziguben Granule inhibiting EMT through Nrf2-mediated anti-oxidative effects in streptozotocin (STZ)-induced diabetic rats.
    Zhang C, Li Q, Lai S, Yang L, Shi G, Wang Q, Luo Z, Zhao R, Yu Y.
    J Ethnopharmacol; 2017 Jun 09; 205():207-216. PubMed ID: 28501426
    [Abstract] [Full Text] [Related]

  • 37. Hepatoprotective evaluation of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic: In vitro and in vivo studies.
    Ai G, Liu Q, Hua W, Huang Z, Wang D.
    J Ethnopharmacol; 2013 Apr 19; 146(3):794-802. PubMed ID: 23422335
    [Abstract] [Full Text] [Related]

  • 38. Design, synthesis, and biological evaluation of a novel dual peroxisome proliferator-activated receptor alpha/delta agonist for the treatment of diabetic kidney disease through anti-inflammatory mechanisms.
    Liu K, Zhao X, Qi X, Hou DL, Li HB, Gu YH, Xu QL.
    Eur J Med Chem; 2021 Jun 05; 218():113388. PubMed ID: 33784603
    [Abstract] [Full Text] [Related]

  • 39. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
    Zhang Y, Cui Y, Wang XL, Shang X, Qi ZG, Xue J, Zhao X, Deng M, Xie ML.
    Cytokine; 2015 Sep 05; 75(1):127-35. PubMed ID: 26194065
    [Abstract] [Full Text] [Related]

  • 40. Pretreatment with the total flavone glycosides of Flos Abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy.
    Zhou L, An XF, Teng SC, Liu JS, Shang WB, Zhang AH, Yuan YG, Yu JY.
    J Med Food; 2012 May 05; 15(5):461-8. PubMed ID: 22439874
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 92.